Amazon faces NYC headwinds

The New York backlash to Amazon’s big HQ2 announcement came swiftly last week, said Sam Raskin in Curbed.com. New York and the Washington area were the winners of Amazon’s competition, but not everyone there is happy about it. New York’s often warring mayor and governor both support the deal, pointing to 40,000 jobs and $30 billion in city and state tax revenue over 25 years. But opponents, including a host of local politicians, have lined up with objections to a deal that includes nearly $3 billion in subsidies for a company that “surely has enough money to build an office without any public dollars.” Fears of soaring apartment prices and public transit snarls are other top concerns. Amazon’s plan to move in, with a helipad, next to New York’s biggest low-income housing project, also threatens to make the giant new center a symbol of inequality. pregnancy. But those are simpler, “singleprotein” tests; “complex disease fingerprints with swarms of proteins are exceptionally difficult (and time-consuming) to spot.” Biotech startup SomaLogic is using AI to screen proteins in a patient’s body to detect nascent diseases before there are outward symptoms. The ultimate goal is to offer a $100 screen that could provide specific insight into ailments like Alzheimer’s, cancer, and cardiovascular disease, but more progress is needed. Larry Gold, a biochemist and founder of SomaLogic, says the “science is hard—harder than I thought.”